Richard Fuhler
Internal Medicine · Mobile, ALNPI 1922110535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 284 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,076 and has fallen 80.1% since, to $214 in 2025.
Across 284 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neos Therapeutics, LP$970
- Corium, LLC$892
- Ironshore Pharmaceuticals Inc.$696
- Tris Pharma Inc$567
- Takeda Pharmaceuticals U.S.A., Inc.$383
- Supernus Pharmaceuticals, Inc.$249
- plus $747 from 7 others
What the payments were for
- Food & beverage$4,504100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neos Therapeutics, LP | 72 | $970 |
| Corium, LLC | 45 | $892 |
| Ironshore Pharmaceuticals Inc. | 32 | $696 |
| Tris Pharma Inc | 21 | $567 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $383 |
| Supernus Pharmaceuticals, Inc. | 17 | $249 |
| Arbor Pharmaceuticals, Inc. | 26 | $242 |
| Adlon Therapeutics L.p. | 20 | $232 |
| Shire North American Group Inc | 11 | $190 |
| AbbVie | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,504 in reported general payments places this provider in the 85th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 15 | $3,475 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $1,554 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $573 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mobile
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Bobby WrightsMobile$89K
- Rahel AzizMobile$67K
- Jamie CaudillMobile$52K
- Lin LiMobile$45K
- Edward CarlosMobile$26K
- Donald SandersMobile$23K
- Amy StrassburgMobile$18K
- Roger AlvaradoMobile$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.